Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,746 | -55 | -23 | -10 | -2,421 |
| Depreciation Amortization | 311 | N/A | N/A | N/A | 123 |
| Accounts receivable | 412 | N/A | N/A | N/A | -534 |
| Other Working Capital | 291 | -15 | -25 | -20 | 159 |
| Other Operating Activity | 1,526 | 0 | 0 | 0 | 924 |
| Operating Cash Flow | $-3,206 | $-70 | $-49 | $-31 | $-1,749 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -844 | N/A | N/A | N/A | -1,291 |
| Other Investing Activity | -59 | 0 | 0 | 0 | -45 |
| Investing Cash Flow | $-903 | $N/A | $N/A | $N/A | $-1,336 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 800 |
| Debt Repayment | -1,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 8,373 | N/A | N/A | N/A | 2,546 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -45 |
| Financing Cash Flow | $7,373 | $N/A | $N/A | $N/A | $3,301 |
| Beginning Cash Position | 1,477 | 564 | 564 | 564 | 1,261 |
| End Cash Position | 4,741 | 494 | 515 | 533 | 1,477 |
| Net Cash Flow | $3,264 | $-70 | $-49 | $-31 | $216 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,206 | -70 | -49 | -31 | -1,749 |
| Capital Expenditure | -844 | N/A | N/A | N/A | -1,291 |
| Free Cash Flow | -4,050 | -70 | -49 | -31 | -3,040 |